Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets.
Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage.
Regulation of intestinal calcium absorption by luminal calcium content: role of intestinal alkaline phosphatase.
Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase.
A role for intestinal alkaline phosphatase in the maintenance of local gut immunity.
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition.
Local peritoneal irrigation with intestinal alkaline phosphatase is protective against peritonitis in mice.
Vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) induces intestinal alkaline phosphatase gene expression.
Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota.
Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.
Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease.
Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis.